BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 699970)

  • 1. Dopamine receptor binding of 3H-ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) regulated by guanyl nucleotides.
    Creese I; Snyder SH
    Eur J Pharmacol; 1978 Aug; 50(4):459-61. PubMed ID: 699970
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in guanine nucleotide sensitive and insensitive 3H-ADTN binding in striatum following substantia nigra lesions.
    Hirschhorn ID; Makman MH; Gardner EL
    Eur J Pharmacol; 1980 Mar; 62(1):123-4. PubMed ID: 6154585
    [No Abstract]   [Full Text] [Related]  

  • 3. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
    Clement-Cormier Y; Abel M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptor binding regulated by guanine nucleotides.
    Creese I; Usdin TB; Snyder SH
    Mol Pharmacol; 1979 Jul; 16(1):69-76. PubMed ID: 481426
    [No Abstract]   [Full Text] [Related]  

  • 5. ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene): a prototype for possible dopaminergic false transmitters?
    Roberts PJ; Davis A
    Adv Biochem Psychopharmacol; 1978; 19():177-91. PubMed ID: 696460
    [No Abstract]   [Full Text] [Related]  

  • 6. Retina contains guanine nucleotide sensitive and insensitive classes of dopamine receptors.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Eur J Pharmacol; 1980 May; 63(2-3):217-22. PubMed ID: 6155277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereospecific binding of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat brain dopamine receptors [proceedings].
    Davis A; Poat JA; Woodruff GN
    Biochem Soc Trans; 1979 Feb; 7(1):147-8. PubMed ID: 437261
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices.
    Mulder AH; Braakhuis B; De Regt V; Dijkstra D; Horn AS
    Eur J Pharmacol; 1980 Jun; 64(4):349-55. PubMed ID: 7389827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of a conformationally restricted dopamine analogue, 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, to receptors on rat brain synaptic membranes.
    Roberts PJ; Woodruff GN; Poat JA
    Mol Pharmacol; 1977 May; 13(3):541-7. PubMed ID: 17829
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) as a ligand for brain dopamine receptors [proceedings].
    Cross AJ; Crow TJ; Owen F
    Br J Pharmacol; 1979 May; 66(1):87P. PubMed ID: 454971
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine receptor binding: specificity, localization and regulation by ions and guanyl nucleotides.
    Creese I; Prosser T; Synder SH
    Life Sci; 1978 Aug; 23(5):495-9. PubMed ID: 692273
    [No Abstract]   [Full Text] [Related]  

  • 12. The uptake and release of [3-H]-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthlane (ADTN) by striatal nerve terminals.
    Davis A; Roberts PJ; Woodruff GN
    Br J Pharmacol; 1978 May; 63(1):183-90. PubMed ID: 647158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat striatal membranes. Effects of purine nucleotides and ultraviolet irradiation.
    Zahniser NR; Heidenreich KA; Molinoff PB
    Mol Pharmacol; 1981 May; 19(3):372-8. PubMed ID: 7266464
    [No Abstract]   [Full Text] [Related]  

  • 14. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat brain synaptic membranes: association with the dopamine (3,4-dihydroxyphenethylamine) receptor.
    Roberts PJ; Woodruff GN; Poat JA
    Biochem Soc Trans; 1976; 4(2):316-7. PubMed ID: 1001677
    [No Abstract]   [Full Text] [Related]  

  • 16. Endogenous guanyl nucleotides: components of the striatum which confer dopamine-sensitivity to adenylate cyclase.
    Kebabian JW; Chen TC; Cote TE
    Commun Psychopharmacol; 1979; 3(6):421-8. PubMed ID: 546590
    [No Abstract]   [Full Text] [Related]  

  • 17. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL; Krstich M; Beart PM
    Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of guanine nucleotides on striatal dopamine receptors.
    Zahniser NR; Molinoff PB
    Nature; 1978 Oct; 275(5679):453-5. PubMed ID: 692725
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats.
    De Blasi A; Mennini T
    Brain Res; 1982 Jun; 242(2):361-4. PubMed ID: 7116143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.